Morningstar Founder Mansueto Trims Daily; Still 37.5% Owner

Morningstar founder Joseph D. Mansueto continued his steady, small-lot disposition of MORN stock through May 12, 2026, selling roughly $3.3M across nine trading days at prices between $175 and $180 per share. The pattern is consistent with a long-running 10b5-1-style rhythm: small daily lots, frequent files, no single block trade. Form 4 filings show share counts ranging from 18 shares to 7,232 shares per print.

That headline number is the kind of insider activity retail readers see and worry about. The 13G context tells a different story. Mansueto's latest Schedule 13G/A, filed February 12, 2026, reports a 37.5% beneficial stake (14,909,759 shares) in Morningstar — making him by far the largest beneficial owner of the company he founded in 1984. The recent Form 4 sales represent under 0.1% of his total beneficial position. That is not divestment; it is portfolio housekeeping.

The transaction record

Form 4 transactions filed by Mansueto across May 7-12, 2026:

After the May 12 prints, the SEC filing shows 8,088,740 directly-held shares remaining in the reporting account, alongside the 14,909,759-share beneficial position reported on the 13G/A. The two figures are not in conflict: Form 4 reports the registered account that originates the sells, while Schedule 13G/A aggregates all holdings — direct, family entities, foundations — that contribute to beneficial ownership.

The 37.5% reality check

This matters because the same Form 4 cycle, read alone, has misled retail discussion of Mansueto's intent multiple times since 2021. Mansueto's daily disposition cadence has been roughly $1-2M per trading day on average — visible, mechanical, and a fraction of one percent of his stake even over a calendar year. A separate February 2026 13G/A from Daniel Mansueto (a family member) reports a 9.5% stake of 3,757,306 shares. Aggregating family beneficial ownership puts the Mansueto family at roughly 47% of Morningstar — a controlling position by any reasonable definition.

The historical 13G/A trail also reveals that the company-level filings have evolved. The November 2025 13G/A from Morningstar, Inc. reports a 36.2% stake (15,037,534 shares), down from 35.8% in February 2025 and the 14.9M reported by Mansueto personally. These are not duplicate filings — they reflect the reporting-entity structure where Mansueto's personal holdings and entity-attributed holdings appear on different schedules.

Who else owns MORN

Outside the founder family, MORN's 13F holder base is dominated by long-duration active managers. Select Equity Group holds $0.33B, BAMCO Inc (Ron Baron's firm) holds $0.27B, Wellington Management $0.25B, and AQR Capital Management $0.20B. The first three are precisely the long-duration growth seats you would expect to see on a founder-controlled compounder. Morgan Stanley's $0.44B sits across asset-management and wealth-platform sleeves.

Of the top-10 reported MORN 13F holders, only Geode Capital Management ($0.13B) is flagged as a passive index sub-advisor. The rest are active. That's a meaningfully concentrated, conviction-heavy float for a stock the founder controls 37.5% of — and one of the reasons MORN's small share-by-share trading rhythm rarely produces sustained price moves.

What the systematic pattern means

Mansueto's selling cadence has the technical fingerprints of a Rule 10b5-1 plan: lots of small same-day prints, consistent across multi-month windows, no clustering around earnings or corporate events. Form 4 page footnotes from prior years have explicitly cited 10b5-1 plan adoptions, though the latest filings would need to be read individually to confirm the plan is still in force. Under SEC Rule 10b5-1, an executive who pre-commits a trading schedule receives an affirmative defense against insider-trading allegations — the price and date are set before the trades execute. The mechanical signature here is consistent with that framework.

That framing matters because a discretionary $3.3M sale by the founder of a public company would be a story — a 10b5-1 drip is portfolio liquidity management. The 13G/A confirms it: someone unwinding conviction does not stop at 37.5%.

The watch list

The data anchors that would change this read: (1) a 13G/A filing in late 2026 showing Mansueto's beneficial percentage dropping below 30% — that would be a real signal of disposition, not housekeeping; (2) a Morningstar 8-K describing changes in Mansueto's reporting structure, governance role, or any acceleration of Form 4 prints into single-day blocks rather than small lots; (3) any change in the family aggregate that brings the Mansueto-attributed stakes below combined 40%.

The Q1 2026 13F amendment deadline closes mid-May 2026, and the Q2 deadline is mid-August. The next 13G amendment from the company would be expected around the same window. Until then, the next material disclosure on Mansueto's career trading history will be incremental Form 4 prints in the same cadence.

How retail investors should read this

The data integrity rule here is the one that catches most market commentary: Form 4 sells do not equal exit when 13G/A beneficial ownership remains high. The latest Schedule 13G/A is the source of truth on whether a founder has stepped back from the company; Form 4 prints are the source of truth on what changed during a specific window. They are complementary, not interchangeable, and reading only Form 4 is how the "founder dumps stock" headlines get written about transactions that are 0.05% of a 37.5% stake.

For active monitoring of MORN insider activity and beneficial ownership disclosures, the Morningstar issuer page aggregates 13F holder data and 13D/G filings, and the broader insights feed surfaces cluster-trade alerts when multiple insiders or institutional holders move within the same window. The learn library covers the methodological details on 10b5-1 plan reading and Form 4 vs 13G/A cross-checks.

Bottom line

Joe Mansueto sold roughly $3.3M of MORN stock across nine trading days through May 12, 2026, in small mechanical lots consistent with a long-running 10b5-1 cadence. The headline number is real; the framing is not divestment. The founder's 37.5% beneficial stake per the most recent Schedule 13G/A means the recent prints are less than a tenth of one percent of his ownership. Until the percentage on the 13G/A line moves materially, the systematic small-lot pattern is the right read on intent.